March 26, 2021 02:51 PM EDTUpdated 03:13 PM
Pharma
FDA+

House Dems call on the FTC to in­ves­ti­gate po­ten­tial col­lu­sion among top three in­sulin man­u­fac­tur­ers

Zachary Brennan

Senior Editor

Strik­ing while the iron is hot, six House De­moc­rats sent a let­ter Thurs­day to the act­ing chair­woman of the FTC (10 days af­ter the FTC …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

Nether­lands pours $1.5B in­to biotech in pur­suit of glob­al lead­er­ship am­bi­tions

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times